Cytogel Pharma

Darien, CT · Founded 2006 · Privately Held (backing)

Operator of a bio-pharmaceutical company intended to assist with the discovery and development of safe and innovative treatments to finally resolve moderate to severe pain. Cytogel Pharma is based in Darien, CT and was founded in 2006. It was valued at $47 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $32.8 million across 4 recorded rounds; the latest was a $1.8 million seed round in Jun 2023.

PMV mark · valuation
$47.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$32.8M
Last round
Seed Round
Jun 2023

Who backs Cytogel Pharma?

5 investors
InvestorType
New Ground Ventures—
Westway Capital—
Centripetal Capital Partners—
Cytogel Venture—
John Fernandes—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cytogel Pharma investors

5 investors are on record for Cytogel Pharma, including New Ground Ventures, Westway Capital, Centripetal Capital Partners and Cytogel Venture. The seed round in Jun 2023 drew 18 investors.

Free account
More of Cytogel Pharma with a free account
  • ·Watch Cytogel Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Cytogel Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View